Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis

Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis

Abstract Background Therapeutic drug monitoring (TDM) of vancomycin is widely recommended for clinical treatment. Due to the complexity of 24-h area under the curve (AUC) guided vancomycin monitoring in clinical practice, the vancomycin trough level remains the most common and practical method. The...

Full description

Bibliographic Details
Main Authors:	Xiaowu Zhang, Yulin Wu, Donghao Wang
Format:	Article
Language:	English
Published:	BMC 2024-01-01
Series:	BMC Infectious Diseases
Subjects:	Vancomycin Gastrointestinal cancer Therapeutic drug monitoring
Online Access:	https://doi.org/10.1186/s12879-023-08885-7

Similar Items

Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort
by: Juhaina Salim Al-Maqbali, et al.
Published: (2022-05-01)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021-11-01)

The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
by: Paul Firman, et al.
Published: (2022-12-01)

Extremely high levels of vancomycin can cause severe renal toxicity
by: Barceló-Vidal J, et al.
Published: (2018-07-01)

Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring
by: Ashley Chen, et al.
Published: (2022-12-01)

Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
by: Yun Kim, et al.
Published: (2022-01-01)

Comparison of vancomycin serum levels prior to and post therapeutic drug monitoring in patients admitted to hospital
by: Kaveh Eslami, et al.
Published: (2021-09-01)

Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011-01-01)

Prospective validation of neonatal vancomycin dosing regimens is urgently needed
by: Anaïs Vandendriessche, MD, et al.
Published: (2014-12-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental Study
by: Yazed Saleh Alsowaida, et al.
Published: (2022-09-01)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021-12-01)

What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
by: Bruce R. Dalton
Published: (2023-02-01)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
by: Kui-fen Ma, et al.
Published: (2020-10-01)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021-08-01)

Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics
by: Borisov A.M., et al.
Published: (2020-03-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)

Simple and rapid method for analysis of urinary vancomycin using solid phase extraction and fluorescence spectroscopy
by: Yuki Oshima, et al.
Published: (2023-02-01)

Clinical Relevance of a Vancomycin 24 h Area under the Concentration—Time Curve Values Using Different Renal Function Equations in Bayesian Dosing Software
by: Hyun-Ki Kim, et al.
Published: (2023-01-01)

Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation
by: Chien-Chih Wu, et al.
Published: (2016-07-01)

Vancomycin treatment: analysis of efficacy and safety
by: Brigita Mavsar-Najdenov, et al.
Published: (2007-11-01)

Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies
by: Matylda Resztak, et al.
Published: (2021-11-01)

Early Vancomycin Concentrations and the Applications of a Pharmacokinetic Extrapolation Method to Recognize Sub-Therapeutic Outcomes
by: Oscar Santalo, et al.
Published: (2016-11-01)

Vancomycin Flight Simulator: A Team-Based Learning Exercise
by: Nicholas W. Carris, et al.
Published: (2023-01-01)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
by: Dae Il Kim, et al.
Published: (2010-12-01)

Is vancomycin monitoring of real value in pediatric cancer patients?
by: Mohamed S. Imam, et al.
Published: (2018-03-01)

A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study
by: Takayuki Miyai, et al.
Published: (2020-12-01)

Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
by: Adam Frymoyer, et al.
Published: (2020-04-01)

The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
by: Yuyan Pan, et al.
Published: (2020-05-01)

Population Pharmacokinetics of Vancomycin in Pregnant Women
by: Rahul K. Goyal, et al.
Published: (2022-06-01)

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis
by: A. B. Prokofiev, et al.
Published: (2022-07-01)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
by: Maluangnon C, et al.
Published: (2022-12-01)

Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration
by: Yuriko Ito, et al.
Published: (2023-05-01)

Measuring and improving the timeliness of vancomycin therapeutic drug monitoring and potential patient safety impacts
by: Belinda Chappell, et al.
Published: (2024-03-01)

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
by: Lore Thijs, et al.
Published: (2022-05-01)

Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease
by: Ahmad Khoei, et al.
Published: (2019-01-01)

Therapeutic Drug Monitoring for Evaluation of the Efficacy and Safety of Vancomycin in Patients with Orthopaedic Infections
by: O. S. Tufanova, et al.
Published: (2022-07-01)

A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
by: Leonore Greybe, et al.
Published: (2023-11-01)

AI Models to Assist Vancomycin Dosage Titration
by: Zhiyu Wang, et al.
Published: (2022-02-01)